[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Pages 5086-5087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-2059]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-10-0745]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Colorectal Cancer Screening Program (OMB Number 0920-0745, exp. 7/
31/2010)--Revision--Division of Cancer Prevention and Control (DCPC), 
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Colorectal Cancer (CRC) is the second leading cause of cancer-
related deaths in the United States, following lung cancer. Based on 
scientific evidence which indicates that regular screening is effective 
in reducing CRC incidence and mortality, regular CRC screening is now 
recommended for average-risk persons. Screening tests that are 
recommended by the United States Preventive Services Task Force, and 
that may be used alone or in combination, include fecal occult blood 
testing (FOBT), fecal immunochemical testing (FIT), flexible 
sigmoidoscopy, colonoscopy, and/or double-contrast barium enema (DCBE).
    In 2005, CDC established a three-year demonstration program, 
subsequently extended to four years, to screen low-income individuals 
50 years of age and older who have no health insurance or inadequate 
health insurance for CRC. The five demonstration sites report 
information to CDC including de-identified, patient-level demographic, 
screening, diagnostic, treatment, outcome and cost reimbursement data 
(OMB No. 0920-0745, exp. 7/31/2010). The information is being used to 
assess the feasibility and cost effectiveness of a publicly funded 
screening program and describe key outcomes, and has been critical in 
guiding the expansion of the program.
    CDC will request OMB approval to continue the information 
collection for three years, with changes. First, the number of funded 
sites will increase from 5 to 26, and the term ``Demonstration'' will 
be deleted from the title of the program. Second, there will be a 
reduction in the burden per respondent associated with the collection 
of clinical information. Reporting forms for medical complications and 
medically ineligible clients will be discontinued, and reporting forms 
for colorectal cancer clinical data elements (CCDE) will be 
streamlined. Data elements that were underused in analysis of the 
demonstration program data, or difficult to standardize across 
programs, will be removed, and the level of detail collected from 
endoscopy and pathology reports will be reduced. As a result, the 
reporting burden per CCDE form will be similar regardless of primary 
test provided. Third, the collection of patient-level reimbursement 
cost data will be discontinued and will be replaced by the collection 
of program-level activity-based cost data. The revised information 
collection will utilize a Cost Assessment Tool (CAT) currently in use 
by another CDC-funded cancer program (OMB No. 0920-0812, exp. 6/30/
2012). The information to be collected through the CAT will allow CDC 
to compare activity-based costs across multiple sites and programs, and 
will provide a more effective means of monitoring and improving the 
performance and cost-effectiveness of the CRC screening program.
    The goals of the expanded CRC screening program are to increase 
population-based screening and to reduce health disparities in CRC 
screening, incidence and mortality. The program will continue to 
provide services to low-income individuals age 50 and older with 
inadequate or no health insurance. Each site will screen an estimated 
375 patients per year (186 semiannually). The increase in the number of 
funded sites and the proposed changes will result in an

[[Page 5087]]

overall increase in burden to respondents.
    CCDE information will be transmitted to CDC electronically twice 
per year. Information collected through the Cost Assessment Tool will 
be transmitted electronically to CDC once per year. Participation is 
required for all sites funded through the CRC screening program. There 
are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondents           Form type       respondents    responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Colorectal Cancer Screening     Clinical Data                 26             375           15/60           2,438
 Programs.                       Elements.
                                Cost Assessment               26               1              22             572
                                 Tool.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           3,010
----------------------------------------------------------------------------------------------------------------


    Dated: January 26, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-2059 Filed 1-29-10; 8:45 am]
BILLING CODE 4163-18-P